NUCLEOTIDE SEQUENCE EXPRESSING AN EXTRACELLULAR VESICLE-ANCHORING PROTEIN FUSED WITH SARS-COV-2 ANTIGENS AND RELATED FUSION PROTEIN FOR USE AS VACCINE - Patent 4259191

(19)

(11)

EP 4 259 191 A1

(12)

(43)	Date of publication:
	18.10.2023 Bulletin 2023/42

(21)	Application number: 21830524.1

(22)	Date of filing: 13.12.2021

(51)

International Patent Classification (IPC):

A61K 39/00^(2006.01)
A61K 39/385^(2006.01)

A61K 39/12^(2006.01)
A61P 31/14^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61K 39/12; A61K 39/0011; A61K 39/385; A61K 2039/53; A61K 2039/572; A61K 2039/6075; C12N 2770/20034; A61P 31/14

(86)	International application number:
	PCT/IT2021/050405

(87)	International publication number:
	WO 2022/130432 (23.06.2022 Gazette 2022/25)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

14.12.2020 IT 202000030740

(71)	Applicant: Istituto Superiore di Sanità
	00161 Roma (IT)

(72)	Inventor:
	FEDERICO, Maurizio Paolo Maria 00161 Roma (IT)

(74)	Representative: Gitto, Serena et al
	Barzanò & Zanardo Roma S.p.A. Via Piemonte, 26 00187 Roma 00187 Roma (IT)

(54)	NUCLEOTIDE SEQUENCE EXPRESSING AN EXTRACELLULAR VESICLE-ANCHORING PROTEIN FUSED WITH SARS-COV-2 ANTIGENS AND RELATED FUSION PROTEIN FOR USE AS VACCINE